Application of Dendritic Cell Vaccines in COVID-19

Simple item page
dc.contributor.advisorYasmin, Hasina
dc.contributor.authorKhan, Md. Shohan
dc.date.accessioned2023-01-15T09:13:17Z
dc.date.available2023-01-15T09:13:17Z
dc.date.issued2022-02
dc.descriptionCataloged from PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 01-12).
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
dc.description.abstractImmunotherapy may hold promise as a treatment for coronavirus disease, the greatest epidemic this generation has seen, a disease that has wreaked havoc on the world's health and economic systems. We believe that using DC vaccine therapy as a treatment method for COVID-19 could be beneficial. Due to their immune-compromised status, cancer patients are among the most vulnerable people. In this review, the various approaches and conventional technologies employed to develop vaccines against COVID-19 will be compared with dendritic cell vaccines to show how dendritic cell vaccines can be a ray of hope for the world to be a healthy place again and also how it can boost up the overall vaccination process.
dc.identifier.otherID: 18146030
dc.identifier.otherhttps://dspace.bracu.ac.bd/server/api/core/items/ea14ab20-60ab-43ce-9e61-47990b71933d
dc.identifier.urihttp://hdl.handle.net/10361/17720
dc.language.isoen_US
dc.publisherBRAC University
dc.sourceBRAC University Institutional Repository
dc.subjectDendritic cell
dc.subjectVaccines
dc.subjectCOVID-19
dc.subjectImmune-response
dc.subjectCytokines
dc.titleApplication of Dendritic Cell Vaccines in COVID-19
dc.typeThesis

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
18146030_PHR.pdf
Size:
446.66 KB
Format:
Adobe Portable Document Format
Download

Collections

Project report & Thesis (Bachelor of Pharmacy)